A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

TY - JOUR

T1 - A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

AU - Wilson, A. M.

AU - Orr, L. C.

AU - Coutie, W. J. R.

AU - Sims, E. J.

AU - Lipworth, B. J.

PY - 2002/1

Y1 - 2002/1

N2 - The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.

AB - The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.

U2 - 10.1046/j.0022-0477.2001.01252.x

DO - 10.1046/j.0022-0477.2001.01252.x

M3 - Article

C2 - 12002729

SN - 0954-7894

VL - 32

SP - 126

EP - 132

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 1

ER -